Clinical trials
Fallopian Tube Neoplasms trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Terminated | 4 |
| Withdrawn | 1 |
| Suspended | 1 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Medical University Innsbruck | 2 |
| AGO Study Group | 1 |
| Clovis Oncology, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
| Krankenhaus Barmherzige Schwestern Linz | 1 |
| Medical Research Council | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 20 |
| Ovarian Neoplasms | 16 |
| Carcinoma, Ovarian Epithelial | 8 |
| Peritoneal Neoplasms | 3 |
| Adenocarcinoma, Clear Cell | 1 |
| Disorders of Sex Development | 1 |
| Endometrial Neoplasms | 1 |
| Genital Neoplasms, Female | 1 |
| Neoplasm Metastasis | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.